Physician

Andrej A Petrov, MD

According to 2025 Medicare claims, Andrej Petrov, MD (NPI: 1538134069) practices allergy/immunology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PITTSBURGH PHYSICIANS (NPI: 1811955230; TIN: 232919472) and primary practice location at 15213-2536.

Petrov's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 155 traditional Medicare patients, billed 771 HCPCS/CPT codes, and received $22,717 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,711 prescription claims across 209 beneficiaries totaling $1,338,757 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 166 claims. Open Payments data shows 38 records totaling $12,187. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $207,104 to $1,338,757. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,068 and ending at $3,727.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	150	311	$20,307
2016	132	283	$17,847
2017	145	314	$20,034
2018	146	433	$22,309
2019	165	673	$27,064
2020	145	469	$20,684
2021	210	929	$27,661
2022	169	741	$21,011
2023	146	719	$18,806
2024	155	771	$22,717

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	830	$207,104
2016	133	852	$150,453
2017	158	933	$231,190
2018	187	1,142	$378,126
2019	178	1,201	$464,004
2020	193	1,426	$874,248
2021	204	1,388	$1,166,469
2022	199	1,475	$1,586,376
2023	193	1,582	$1,585,876
2024	209	1,711	$1,338,757

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	243	$442,981
2016	N/R	200	$345,605
2017	N/R	183	$238,759
2018	N/R	179	$220,814
2019	N/R	185	$226,006
2020	N/R	208	$286,958
2021	N/R	174	$255,473
2022	N/R	180	$322,056
2023	N/R	143	$261,926
2024	N/R	166	$313,765

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	14	17	$131
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	24	24	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	111	147	$77
94060	Test to measure expiratory airflow and volume changes before and after medication administration	20	21	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	25	700	$229,133
Dupixent Syringe	Dupilumab	56	1,568	$218,822
Xolair	Omalizumab	72	2,016	$151,093
Fasenra Pen	Benralizumab	23	1,288	$129,578
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	13	364	$95,795

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	24	$142,475
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$66,893
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	15	$46,358
J1556	Injection, immune globulin (bivigam), 500 mg	N	N/R	13	$45,158
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	28	$9,230

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$12,187	Eli Lilly and Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrej A. Petrov, MD?

Tedicare shows public-source Medicare data for Andrej A. Petrov, MD (NPI 1538134069), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrej A. Petrov, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrej A. Petrov, MD?

Andrej A. Petrov, MD is linked to UNIVERSITY OF PITTSBURGH PHYSICIANS (billing NPI 1811955230) in the available physician profile data.

Does Andrej A. Petrov, MD have Open Payments data?

Andrej A. Petrov, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.